WithdrawnPhase 3

Efficacy, Safety LactiSal 1% Gel, LactSal 50 mg, Clotrimazole 100 mg Tablet in Treatment Vulvovaginal Candidiasis

Stopped: Development project stopped

0Started 2018-12

Plain-language summary

The purpose of this study is to compare the efficacy and safety of LactiSal 1%vaginal gel and LactiSal 50 mg vaginal tablet with the standart treatment of clotrimazole 100 mg vaginal tablet in woman with vulvovaginal candidiasis (VVC)

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Clinical signs \& symptoms of VVC as Total Severity Score, TSC 4 (range 0-15):
✓. Direct microscopy (Wet smear) positive for yeast forms (hyphae, pseudohyphae) or budding yeasts
✓. Normal vaginal pH (≤4.5)
✓. Age: 18 years and older
✓. Signed Written Informed Consent to participate in this study.

What they're measuring

Clinical cure rate

Timeframe: 10 days after entry (C1)

Trial details

NCT IDNCT02907307

SponsorMedinova AG

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2019-12

View on ClinicalTrials.gov More Vulvovaginal Candidiasis trials